the frequency distributions of the various induced malformations and combined malformations of a positive control group ( 30 mg/kg b.w . of cyclophosphamide on the 11.5th day of pregnancy ) were compared to those found in groups receiving different doses of the prophylactic .
C0010583
cyclophosphamide
C0032961
pregnancy